Skip to content

Sanara MedTech Inc. SMTI Ratios & Valuation

TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
Profitability
Gross margin92.9%+0.2pp92.7%+0.5pp92.3%+0.5pp91.8%+0.6pp91.2%+0.6pp
Operating margin6.1%+1.5pp4.6%-1.2pp5.9%+1.9pp3.9%+2.9pp1.1%+2.7pp
Net margin-31.2%+5.2pp-36.4%+0.4pp-36.8%-26.6pp-10.2%+2.3pp-12.5%-1.3pp
EBITDA margin9.3%+0.9pp8.5%-2.2pp10.7%+1.6pp9%+2.6pp6.5%+2.4pp
Returns
Return on equity-153.7%+12.0pp-165.7%-2.4pp-163.2%-137pp-25.8%+2.8pp-28.6%-5.6pp
Return on assets-40.5%+6.1pp-46.7%+0.3pp-47%-35.4pp-11.5%+2.1pp-13.7%-1.7pp
Return on invested capital12.9%+2.6pp10.3%-2.5pp12.8%+6.3pp6.4%+4.7pp1.7%+4.3pp
Efficiency
Asset turnover1.3×0.0×1.3×0.0×1.3×+0.1×1.1×0.0×1.1×0.0×
Inventory turnover2.4×+0.2×2.2×-0.2×2.5×+0.2×2.3×+0.1×2.2×0.0×
Liquidity
Current ratio2.3×+0.5×1.8×0.0×1.8×-0.5×2.3×-0.5×2.8×+0.6×
Quick ratio+0.5×1.6×0.0×1.6×-0.4×-0.5×2.5×+0.5×
Cash ratio+0.1×0.9×0.0×0.9×-0.3×1.1×-0.4×1.6×+0.5×
Leverage
Debt-to-equity6.9×-1.2×8.1×+0.4×7.7×+6.4×1.3×+0.1×1.2×+0.4×
Debt-to-assets0.7×0.0×0.7×0.0×0.7×+0.2×0.5×0.0×0.5×+0.1×
Net debt / EBITDA3.5×-0.1×3.6×+0.6×-0.3×3.2×
Interest coverage0.9×+0.2×0.7×-0.3×+0.2×0.7×+0.5×0.2×+0.7×
Per Share
Book value per share$0.78+13.6%$0.69+0.1%$0.69-83.3%$4.11-3.9%$4.28-7.9%
Valuation
Market capitalization$216.18M-9.7%$208.65M-26.1%$282.47M+11.6%$253.04M-7.9%$274.8M-5.3%
Enterprise value$250.95M-6.5%$240.26M-23.7%$314.92M+11.9%$281.53M-5.8%$298.83M-2.5%
Price / sales-0.5×-0.7×2.8×+0.2×2.6×-0.4×-0.3×
Price / book32.4×+25.3×35.1×-10.8×45.9×+38.8×7.1×-0.3×7.5×+0.1×
EV / EBITDA26.2×-5.7×27.5×-1.4×28.9×-3.1×32.1×
EV / sales2.4×-0.4×2.3×-0.8×3.1×+0.2×2.9×-0.4×3.3×-0.3×
Earnings yield-14.8%-10.8pp-18%-4.7pp-13.3%-9.3pp-3.9%+0.2pp-4.2%-0.8pp

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Sanara MedTech Inc.'s profit margins?
Sanara MedTech Inc. (SMTI) runs a 92.9% gross margin and a 6.1% operating margin, with a -31.2% net margin.
Where do Sanara MedTech Inc.'s ratios come from?
Every ratio is computed from Sanara MedTech Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.